DelSite Biotechnologies, Inc. Patent for GelSite(R) Polymer Technology Issued

IRVING, TX--(Marketwire - November 12, 2008) - DelSite, Inc. (OTCBB: DSII) today announced that the United States Patent and Trademark Office has granted a Notice of Issuance of patent application No. 10/422,867, titled "High Molecular Weight, Low Methoxyl Pectins and their Production and Uses," relating to the Company's proprietary GelSite® polymer technology. DelSite Biotechnologies, Inc., a subsidiary of DelSite, Inc., is developing and commercializing GelSite® polymer as a controlled-release drug delivery technology for therapeutics and vaccine products.
MORE ON THIS TOPIC